Recent insights into experimental mouse models of diabetic nephropathy

被引:34
作者
Tesch, Gregory H.
Nikolic-Paterson, David J.
机构
[1] Monash Med Ctr, Dept Nephrol, Clayton, Vic 3168, Australia
[2] Monash Univ, Dept Med, Monash Med Ctr, Clayton, Vic 3168, Australia
来源
NEPHRON EXPERIMENTAL NEPHROLOGY | 2006年 / 104卷 / 02期
关键词
mouse models; diabetic nephropathy; C57BL/6; streptozotocin; db/db; advanced glycation end products; oxidative stress; fibrosis;
D O I
10.1159/000093998
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Mouse models are an essential experimental tool for investigating the role of molecular mechanisms and genetic susceptibility in the development of diabetic nephropathy. Methods:The most widely used inbred strain, the C57BL/6 mouse, is commonly used in streptozotocin-induced models of type 1 diabetes and is particularly susceptible to obesity-induced type 2 diabetes. However, use of this strain has been criticised by studies suggesting that it is relatively resistant to renal injury. Results: Recent refinement of these models and utilisation of genetically modified (knockout and transgenic) mice on a C57BL/6 background has provided important insights into the roles of oxidative stress, advanced glycation end products, inflammation and pro-fibrotic mechanisms in the development of type 1 and type 2 diabetic nephropathy. Conclusion: These findings demonstrate the utility of mouse models for identifying and testing novel therapeutic strategies which could translate into better protection against the human disease. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:E57 / E62
页数:6
相关论文
共 34 条
[1]   Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy [J].
Adhikary, L ;
Chow, F ;
Nikolic-Paterson, DJ ;
Stambe, C ;
Dowling, J ;
Atkins, RC ;
Tesch, GH .
DIABETOLOGIA, 2004, 47 (07) :1210-1222
[2]   Use of genetic mouse models in the study of diabetic nephropathy [J].
Allen T.J. ;
Cooper M.E. ;
Lan H.Y. .
Current Atherosclerosis Reports, 2004, 6 (3) :197-202
[3]  
[Anonymous], 2004, DIABETES CARE, DOI DOI 10.2337/DIACARE.27.5.1240-A
[4]  
Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2004080648, 10.1681/ASN.2009070721]
[5]   Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury [J].
Chow, F ;
Ozols, E ;
Nikolic-Paterson, DJ ;
Atkins, RC ;
Tesch, GH .
KIDNEY INTERNATIONAL, 2004, 65 (01) :116-128
[6]   Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice [J].
Chow, FY ;
Nikolic-Paterson, DJ ;
Ozols, E ;
Atkins, RC ;
Rollin, BJ ;
Tesch, GH .
KIDNEY INTERNATIONAL, 2006, 69 (01) :73-80
[7]   Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice [J].
Chow, FY ;
Nikolic-Paterson, DJ ;
Ozols, E ;
Atkins, RC ;
Tesch, GH .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (06) :1711-1722
[8]   Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis [J].
Chow, FY ;
Nikolic-Paterson, DJ ;
Atkins, RC ;
Tesch, GH .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (12) :2987-2996
[9]  
Cohen MP, 2000, EXP NEPHROL, V8, P135
[10]   Overexpression of Cu2+/Zn2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice [J].
Craven, PA ;
Melhem, MF ;
Phillips, SL ;
DeRubertis, FR .
DIABETES, 2001, 50 (09) :2114-2125